VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
ASCO 2026: Eli Lilly's Bladder Cancer ADC Achieves Breakthrough 66.7% Response Rate in Treatment-Naïve Patients
ASCO 2026: Eli Lilly's Bladder Cancer ADC Achieves Breakthrough 66.7% Response Rate in Treatment-Naïve Patients
May 30, 2026 15:48 CST Updated 16:23
Share:
